SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,663,986 | +1107.9% | 77,924 | +879.8% | 0.01% | +550.0% |
| Q4 2022 | $303,327 | -76.2% | 7,953 | -72.3% | 0.00% | -87.5% |
| Q3 2021 | $1,272,000 | +54.6% | 28,697 | +98.1% | 0.02% | +77.8% |
| Q2 2021 | $823,000 | -82.8% | 14,489 | -77.3% | 0.01% | -88.2% |
| Q1 2021 | $4,783,000 | +257.2% | 63,907 | +313.0% | 0.08% | +300.0% |
| Q4 2020 | $1,339,000 | +74.3% | 15,475 | -42.1% | 0.02% | -40.6% |
| Q1 2020 | $768,000 | – | 26,738 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |